Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
842 studies found for:    Herceptin
Show Display Options
Rank Status Study
1 Completed
Has Results
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: MM-111 + Herceptin
2 Terminated Neoadjuvant Herceptin in Patients With Breast Cancer
Condition: BREAST CANCER
Intervention: Drug: Herceptin
3 Completed
Has Results
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
Condition: Neoplasms
Intervention: Drug: Herceptin
4 Suspended Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: Herceptin
5 Completed
Has Results
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Herceptin
6 Recruiting Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
Conditions: HER-2 Positive Gastric Cancer;   Liver Metastasis
Interventions: Drug: Oxaliplatin plus Capecitabine;   Drug: Herceptin
7 Active, not recruiting
Has Results
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Herceptin
8 Active, not recruiting Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Lapatinib;   Drug: Herceptin
9 Completed
Has Results
A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females
Condition: Breast Cancer
Intervention: Drug: Herceptin
10 Recruiting microRNA of Human Epidermal Growth Factor Receptor 2 (HER2)Positive Patient Treated With Herceptin
Condition: Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Trastuzumab
11 Completed
Has Results
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
Condition: Ductal Carcinoma In Situ
Intervention: Drug: Herceptin (Trastuzumab)
12 Completed A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer
Condition: HER2 Positive Early or Locally Advanced Breast Cancer
Interventions: Drug: Herceptin (trastuzuamb);   Drug: SB3 (proposed trastuzumab biosimilar)
13 Active, not recruiting Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Trastuzumab
14 Completed
Has Results
An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)
Condition: Breast Cancer
Intervention: Drug: Trastuzumab
15 Completed
Has Results
A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2-Positive Metastatic Breast Cancer Patients
Condition: Human Epithelial Receptor (HER)-2 Positive Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel
16 Recruiting Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma
Condition: Esophageal Carcinoma
Intervention: Drug: Pertuzumab, trastuzumab
17 Completed Real World Efficiency of Trastuzumab in Early Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Trastuzumab
18 Active, not recruiting Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.
Condition: Breast Cancer
Interventions: Biological: Trastuzumab;   Biological: HERMyl 1401O Trastuzumab;   Drug: Paclitaxel;   Drug: Docetaxel
19 Not yet recruiting Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Trastuzumab + NK cells
20 Completed Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
Condition: Urologic Neoplasms
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Gemcitabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.